Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-266433

Director sold 643 shares at $249.00 ($160,107)

  • Director acquired 1,429 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2026-06-08 Option exercise 10b5-1 +1,429 31,032 D: show line 1 in the form
Coleman Mark Director 2026-06-10 Sale 10b5-1 −643 $249.00 $160,107 30,389 D: show line 2 in the form
Open-market sales · 643 sh · avg $249.00 · $160,107

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Coleman Mark Director 2026-06-08 Option exercise · Restricted Stock Units 10b5-1 −1,429 0 D: show line 3 in the form
Loading xslF345X06/ownership.xml…